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ABSTRACT 
Our group focuses on the study of mesenchymal stem cells (MSCs) from human umbilical cord stroma or 
Warthońs jelly and their directed differentiation toward chondrocyte-like cells capable of regenerating 
damaged cartilage when transplanted into an injured joint. This study aimed to determine whether lactogenic 
hormone prolactin (PRL) or 3, 3′, 5-triiodo-L-thyronine (T3), the active thyroid hormone, modulates 
chondrogenesis in our in vitro model of directed chondrogenic differentiation, and whether Wnt signalling is 
involved in this modulation. MSCs from human umbilical cord stroma underwent directed differentiation 
toward chondrocyte-like cells by spheroid formation. The addition of T3 to the chondrogenic medium 
increased the expression of genes linked to chondrogenesis like collagen type 2, integrin alpha 10 beta 1, and 
Sox9 measured by quantitative real time polymerase chain reaction (qRT-PCR) analysis. Levels of collagen 
type 2 and aggrecane analyzed by immunohistochemistry, and staining by Safranin O were increased after 14 
days in spheroid culture with T3 compared to those without T3 or only with PRL. B-catenin, Frizzled, and 
GSK-3β gene expressions were significantly higher in spheroids cultured with chondrogenic medium (CM) 
plus T3 compared to CM alone after 14 days in culture. The increase of chondrogenic differentiation was 
inhibited when the cells were treated with T3 plus ML151, an inhibitor of the T3 steroid receptor. This work 
demonstrates, for first time, that T3 promotes differentiation towards chondrocytes-like cells in our in vitro 
model, that this differentiation is mediated by steroid receptor co-activator 2 (SRC2) and does not induce 
hypertrophy.  
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The umbilical cord stroma or Warthońs jelly, is a promising source of mesenchymal stem cells 
(MSCs) [Arufe et al., 2011a; Subramanian et al., 2015]. The umbilical cord is a disposable tissue 
and there are no limitations for obtaining umbilical cords from the maternity facilities in hospitals. 
MSCs can be differentiated towards any mesoderm lineage [Arufe et al., 2011b] and also some 
ectodermic lineages, such as neural progenitors [Park et al., 2012]. The chondrogenic 
differentiation of MSCs has been achieved by our group by the use of a defined medium, but the 
levels of aggrecan, the major proteoglycan involved in the composition of the extracellular matrix 
of articular cartilage, did not occur homogeneously [Arufe et al., 2011a; De la Fuente et al., 2012]. 
Lactogenic hormone prolactin (PRL), the product of a single gene synthesized by the pituitary and 
many extra-pituitary tissues, modulates growth, and chondrogenic differentiation of human bone 
marrow-derived MSCs [Ogueta et al., 2002]. Several investigators have focused their studies on 
the chondro-regulatory role of PRL on the tibial growth plate of lactating rats [Suntornsaratoon et 
al., 2010a,2010b,2010c]. It has been established that osteoblasts are a target for PRL in the 
production of new bone formation [Clément-Lacroix et al., 1999] but until now its role into 
chondrogenesis is not clear. Integrin alpha 10 beta 1 (ITGa10) is a protein expressed by 
chondrocytes in hyaline cartilage joint and it is the dominating collagen-binding during cartilage 
development [Camper et al., 2001; Freyria et al., 2009]. Expression of ITGa10 is initiated at the 
beginning of chondrogenesis and continues throughout cartilage development in adult cartilage 
and transcription factor activating enhancer-binding protein epsilon (AP-2ϵ) is involved in the 
regulation of their transcription in chondrocytes [Wenke et al., 2006]. Transcription factor 
activating enhancer-binding protein alpha (AP-2α) is expressed in the growth plate and in articular 
cartilage, and has been described as a negative regulator of chondrocyte differentiation [Huang et 
al., 2004]. We check the expression of all these transcription factors during our study to validate 
our in vitro chondrogenic model. Several studies show that T3 activates Wnt-4 expression and 
Wnt/beta-catenin signalling in rat growth plate chondrocytes [Wang et al., 2007]. Wnt antagonists, 
Frzb/sFRP3 and Dkk1, inhibit T3-induced Wnt/beta-catenin activation and inhibit the maturation-
promoting effects of T3 in growth plate cells. The study by Wang et al. [2007] indicates that 
thyroid hormone regulates terminal differentiation of growth plate chondrocytes, in part through 
modulating Wnt/beta-catenin signalling. This study treats to clarify the role what are playing the 
hormones during chondrogenesis and more concretely the mechanism of T3 action in our model 
which has not been clarified yet, so we have designed our study to examine this question focused 
on SRC2. The SRCs are a family of co-regulators whose interaction with thyroid receptor-β (TRβ) 
have been extensively studied using non-quantitative methods [Darimont et al., 1998; Moore et al., 
2004]. Our study also analyzes the role of SRC2, a steroid co-receptor of T3, in the chondrogenic 
differentiation process, as well as the role of Wnt signalling during chondrogenesis when T3 was 
added. 
  
MATERIALS AND METHODS 
TISSUE COLLECTION 
Human umbilical cords were obtained from caesarean deliveries of ten healthy women in the 
Maternity Facility at Complejo Hospitalario Universitario A Coruña (CHUAC). The women were 
between 26 and 35 years-old. All tissues were obtained with fully informed consent and ethical 
approval under the supervisor of CEIC of Galicia (Ethical Committee of Galicia). 
ISOLATION, CULTURE, AND CHARACTERIZATION OF CELLS 
MSCs were isolated from umbilical cord stroma tissue using an established protocol [Arufe et 
al., 2011b]. Briefly, the Warthońs jelly tissue was washed with PBS and cut in small pieces, 
incubated three times for 5 min with an enzymatic cocktail (1,2 Units/ml dispase and 112 Units/ml 
type I collagenase) and cultured to form explants adhering to plastic plate. After three days, the 
explants were removed, leaving only MSCs attached to the plastic surface. Monolayer cultures of 
these MSCs were cultured in Dulbeccós Modified Eagles Medium (DMEM), 10% fetal bovine 
serum (FBS), 1% penicillin, and 1% streptomycin (all from Sigma–Aldrich, Madrid, SP). When 
the cells achieved 90% confluence, they were characterized by flow cytometry for mesenchymal 
stem cells markers: CD90, CD73, CD105; hematopoietic progenitors: CD34, CD45, and 
endothelial marker: VEGF. After that they underwent directed differentiation towards 
chondrocyte-like cells. 
FLOW CYTOMETRY ANALYSIS 
Cells were washed with PBS twice then pre-blocked with 3% bovine serum albumin (BSA), or 
2–5% serum from the same species, in PBS. The following direct antibodies were used: 
phycoerythrin (PE) mouse anti-human CD34 (1:20 from DakoCytomation, Barcelona, SP); FITC 
mouse anti-human CD45 (1:20 BD Pharmingen, Madrid, SP); FITC mouse anti-human CD105: 
(1:100 from Serotec, Bavaria, Germany): PE-Cy5.5-conjugated mouse anti-human CD90 (1:20 
from BD Pharmingen); PE-conjugated anti-human CD73 (1:20 from BD Pharmingen); and rabbit 
anti-human VEGF (1:20 from DakoCytomation). For detection of primary antibodies not directly 
labelled, the cells were washed with PBS, then incubated with polyclonal rabbit anti-mouse 
IgD/FITC Rabbit F(ab́) 2 (1:1,000 from DakoCytomation) for 30 min at room temperature. The 
stained cells were then washed twice with PBS and 1 × 105 cells were analyzed with a FACSAria 
flow cytometer (BD Bioscience, Madrid, SP). FACS data were generated by DIVA software (BD 
Bioscience). Negative control staining was performed using FITC-conjugated mouse IgG1k 
isotype, PE-conjugated mouse IgG1k isotype and PE-Cy5.5-conjugated mouse IgG1k isotype (all 
from BD Pharmingen). 
CHONDROGENIC DIFFERENTIATION 
MSCs were seeded in 96-well plates (Sarsted Inc., Barcelona, SP) at 2 × 104 cells per well in 
growth medium [(DMEM, 10% FBS, 1% penicillin, 1% streptomycin, 1.5 × 10−4 M 
monothioglycerol (MTG), 5 mg/ml ascorbic acid (AA), 6 μg/ml transferrin (TRANS) (all from 
Sigma–Aldrich)] to achieve spontaneous spheroid formation. The medium was then changed to a 
chondrogenic medium (CM) to direct differentiation towards chondrocyte-like cells and was used 
as the control medium for all experiments. The CM consisted of DMEM, 15% knockout serum 
(GIBCO, Invitrogen, Madrid, SP), and 5 mg/ml AA, 6 μg/ml TRANS, 10 μM dexamethasone 
(DEX), 1 × 10−7M retinoic acid (all from Sigma–Aldrich), and 10 ng/ml recombinant human 
transforming growth factor-beta 3 (TGF-β3) or 10 ng/ml TGF-β3 plus 1, 10, or 100 ng/ml of T3 
(both from Sigma-Aldrich) or 10 ng/ml TGF-β3 plus 10, 100, or 1,000 ng/ml of PRL (from 
Sigma–Aldrich). In addition, several amounts (2.5, 10, or 20 μM) of ML151 (Enamine Ltd, Kiev, 
Ukraine), an inhibitor of the T3 steroid receptor, alone or with 100 ng/ml of T3, were tested. The 
last 200 ng/ml of recombinant human Dickkopf protein family, DKK-1 (Prepotech, London, UK), 
was added to the medium alone or into combination with T3. The medium was changed every 3 
days. The spheroids formed were collected, frozen, and stored at 4°C after 14 days in culture for 
later analysis. 
REAL TIME QUANTITATIVE POLYMERASE CHAIN REACTION (qRT-PCR) ANALYSIS 
Genes codifying for human proteins: collagen type 1 (COL1); collagen type 2, (COL2); 
collagen type 10 (COLX); matrix metalloproteinase-13 (MMP-13); aggrecan (ACAN), alkaline 
phosphatase (ALP); activator protein 2 alpha (AP2α); activator protein 2 epsilon (APϵ), integrin 
alpha 10 beta 1 (ITGA10) and Sox9 were used to determine the expression of markers for 
chondrogenic differentiation or hypertrophy in the spheroids performed. All details are shown in 
Table I. The amplification program consisted of initial denaturation at 92°C for 2 min followed by 
40 cycles from 92°C for 15 s, annealing at 61°C for 30 s, and extension at 72°C for 15 s. PCR 
analyses were done in duplicate, with each set of assays repeated three times. To minimize the 
effects of unequal quantities of starting RNA and to eliminate potential sources of inconsistency, 
relative expression levels of each gene were normalized to ribosomal protein (RPLP) or 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using the 2
−ΔΔCt
 method [Livak and 
Schmittgen, 2001]. Control experiments utilized no reverse transcriptase. 
Table I. Specific Primers for Real-Time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Amplification, 
Listed With Their Annealing Temperature (A.T.) 
Gene name Fw primer Rv primer Gene Bank Access A.T. (°C) 
 
COL1A1 2f2r gtgatgctggtcctgttggt caccatcgtgagccttctct NM_000088 61 
COL2A1 3F3R gtgtcagggccaggatgt tcccagtgtcacagacacagat NM_001844 61 
COL10A1 caccttctgcactgctcatc ggcagcatattctcagatgga NM_000493 61 
RPLP tctacaaccctgaagtgcttgat caatctgcagacagacactgg NM_053275 61 
MMP-13 tttcctcctgggccaaat gcaqacagaaacaagttgtagcc NC_000011.10 61 
ACAN gcctacgaagcaggctatga gcacgccataggtcctga NM_001135.3 61 
GSK3-β tcctgcctgctgaagtgaac tttagctgaggtcttgggcc NM_001146156.1 61 
Frizzled-7 gaggcctgcctgctagaatc ataaggccaaggagacgtgg AB017365.1 61 
β-Catenin cattgtttgtgcagctgcttt caggacaaggaagctgcaga NM_001098210.1 61 
SRC2 ccagcatccctgtacga catccacccagcagga AK301078.1 61 
AP2α gatcctcgcagggactaca gttggacttggacagggac BC017754.1 61 
AP2ϵ gaaatagggacttagctcttgg ccaagccagatccccaactctg NM_178548.3 61 
ITGa10 gtgtggatgcttcattccag gccatccaagacaatgacaa NM_003637.3 61 
Sox9 ctccgggacatgatcagc ggtagtgctgggacatgtgaa NM_000346.3 61 
GAPDH agccacatcgctcagacac gcccaatacgaccaaatcc NC_000012.12 61 
     
 
Fw, forward; Rv, reverse. 
  
PROTEIN ISOLATION AND IMMUNOBLOT ANALYSIS 
Immunoblot analysis was performed on 45 μg of total protein extracted from cultured 
spheroids, as previously described [Matsushime et al., 1994]. The blots were probed with 
antibodies directed against human glycogen synthase kinase (GSK-3β), which phosphorylates β-
catenin in the absence of Wnt signal resulting in its ubiquitination and proteosomal degradation; 
Frizzled-7, a receptor for Wnt; and β-catenin (all from Santa Cruz Biotechnology, Heidelberg, 
GE); tubulin or GAPDH (both from Sigma–Aldrich) were used for housekeeping. A secondary 
anti-mouse antibody (Sigma–Aldrich) was used to visualize proteins using an AmershamTM 
ECL
TM
 Western Blotting Analysis System (GE Healthcare, Amersham Biotechnology, 
Manchester, UK). Ideal concentrations for each antibody were determined empirically. Working 
concentrations were 1:1,000 of the recommended stock solutions. 
HISTOLOGICAL, IMMUNOHISTOCHEMISTRY, AND IMMUNOFLUORESCENCE ANALYSIS 
Spheroids from MSCs of umbilical cord stroma, following differentiation into chondrocyte-like 
cells were frozen in OCT embedding matrix (BDH Chemicals, Poole, UK). Full-depth sections 
(4 μm) were cut using a cryostat and fixed in 4% (w/v) paraformaldehyde (Sigma–Aldrich) in PBS 
at pH 7.6. Some sections were stained with Safranin O (Sigma–Aldrich) to evaluate the 
distribution of proteoglycan in the spheroid. Other sections were immunostained with monoclonal 
antibodies against COL1 (1:5,000) (Abcam, Bristol, UK), COL2 (1:200) (Chemicon, Millipore 
Ibérica S.A, Madrid, SP), COLX (1:1,000) (Sigma–Aldrich), MMP-13 (1:50) (Thermo Scientific, 
Cienytech, Santiago de Compostela, SP) and ALP (1:200) (R&D Systems, Millipore Ibérica S.A, 
Madrid, SP) used as previously described Arufe et al. [2011b]. Biotinylated secondary antibodies 
were detected using a peroxidase-labelled biotin-streptavidin complex (Vectastain Elite kit; Vector 
Laboratories, Peterborough, UK) with diaminobenzidine substrate (Vector Laboratories) (1:1,000). 
Normal mouse serum was used as a negative control, and the sections were not counterstained. 
Immunofluorescence analysis was performed by permeabilizing some sections with PBS 
containing 0.1% Triton X-100 for 10 min, then pre-blocking with 3% BSA or 2–5% serum from 
the same species in PBS. The antibodies used were human anti-β-catenin (Santa Cruz 
Biotechnology) and 4′, 6-diamidino-2-phenylindole (DAPI) was used to counter stain the nucleus. 
Secondary antibody was PE-conjugated anti-mouse (1:1,000 from DakoCytomation). 
ELECTRON MICROSCOPY 
Electron microscopic evaluation and immunogold labelling of spheroids followed previously 
published procedures [Lunstrum et al., 1999]. Briefly, spheroids were fixed by immersion in 1.5% 
glutaraldehyde/1.5% paraformaldehyde containing 0.1% (w/v) tannic acid, followed by 1% OsO4. 
Finally, spheroids were dehydrated, embedded in Spur's epoxy and cut in an ultra microtome. 
Immunogold labelling was performed on slices from spheroid before fixing. Antibody human anti-
COL2 (1:200) (Chemicon, Millipore Ibérica S.A, Madrid, SP) was used followed for incubation 
with gold conjugate anti-mouse IgG secondary antibody (Sigma–Aldrich). JEOL JEM 1010 
transmission electron microscope was used in these experiments. 
DENSITOMETRY ANALYSIS 
AnalySIS Image Processing (Soft Imaging system GmbH V. 5.0, Olympus, Münster, 
Germany) was used to quantify the expression of different antibodies obtained by histochemical 
analysis shown in the plots. Three fields 200 μm2 in size from each antibody—COL1, COL2, 
COLX, MMP-13, ALP-, and Safranin O stain-studied were quantified using arbitrary units for 
histochemistry values provided by the computer program. Values expressed as percentage of 
positive cells for each marker studied were used for histochemistry analysis. Control values for 
immunohistochemistry analysis were used from spheroids incubated with the secondary antibody 
alone. 
STATISTICS 
All experiments were performed in triplicate and one representative is shown. Non-parametric 
statistical analyses were performed by Mann–Whitney-U and Kruskal–Wallis tests using SPSS v 
19. A P-value less than 0.05 was considered statistically significant. All the the data are presented 
as standard error of the mean. 
RESULTS 
CHARACTERIZATION OF MSCs 
Characterization of MSC populations isolated from human umbilical cord stroma was made 
using flow cytometry analysis before chondrogenic differentiation studies to determine their 
percentage of MSCs markers. A high percentage of MSCs were positive for CD73 (>40%), CD90 
(>80%), and CD105 (>45%). The remaining tested markers, VEGF had <1% positive cells, with 





Figure 1. Characterization of mesenchymal stem cells (MSCs) from human umbilical cord stroma 
and their chondrogenic differentiation through spheroid cultures. (A) Characterization of 
mesenchymal stem cells population from human umbilical cord stroma by flow cytometry of the 
surface markers; CD34, CD45, CD73, CD90, CD105, and VEGF. At the top is the name of the 
marker, at the bottom the fluorochrome used. The percentages of positive cells are indicated at the 
top right. (B) Representative images of immunohistochemistry tissue sections with antibodies against 
human collagen type II (COL2) and collagen type I (COL1) protein in spheroids performed with 
MSCs cultured in chondrogenic medium (CM), or CM plus 1,000 ng/ml of prolactin (PRL) 
(CM + PRL) or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (T3) (CM + T3). All images have 
the same magnification (bar = 2 mm). (C) Ratios of COL2/COL1 stain protein obtained from 
densitometry study of slices from spheroids cultured in CM + PRL or CM + T3 after 
immunohistochemistry analysis using anti-human COL1 and COL2 antibodies. (D) Real time 
quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) results: ratio of 
COL2A1/COL1A1 gene expressions in spheroids performed with MSCs cultured in chondrogenic 
medium (CM) or CM plus 10, 100, or 1,000 ng/ml of PRL (P10, P100, and P1,000 respectively) or 
CM plus 1, 10, or 100 ng/ml of T3 (T1, T10, and T100 respectively). RPLP = 60S acidic ribosomal 
protein large P1. *P < 0.05 versus CM by Mann–Whitney-U test. 
  
CHONDROGENESIS STUDY 
COL1 and COL2 gene expression dose-response curves were analyzed for PRL at 10, 100, or 
1,000 ng/ml and T3 at 1, 10, or 100 ng/ml in CM. The dose of 100 ng/ml of T3 resulted in the most 
statistically significant (P < 0.05) increase of COL2 gene expression compared to CM (Fig. 1B). 
Densitometry analyses of COL2 and COL1 protein by immunohistochemistry after 14 days in 
culture were performed using 1,000 ng/ml of PRL and 100 ng/ml of T3. The results revealed that 
the best ratio of COL2/COL1 after 14 days of chondrogenesis was when T3 was added to the 
medium (Fig. 1C and D). Proteoglycans were more abundant in spheroids cultured with T3 
compared with CM or CM plus PRL, as shown by Safranin O staining after 14 days (Fig. 2A) and 
its densitometry analysis (Fig. 2B), the difference was statistically significant (P < 0.05). 
Corroborating these data, the RT-PCR analysis from ACAN gene was statistically significant 
highest (P < 0.05) in spheroid performed into CM plus 100 mg/ml of T3 (Fig. 2C). Spheroid 
cultured during 14 days into chondrogenic medium plus T3 (100 mg/ml) expressed statistically 
significant (P < 0.05) high levels of AP-2α, ITGa10, COL2, and AP2ϵ genes compared with 
spheroid cultured during 14 days into CM alone (Fig. 3A). Spheroid ultra-structure was shown at 
Figure 3B, there were two MSCs where was possible observe a nucleus also was observed the gap 
between cells where no structures inside. In the Figure 3C was shown a spheroid cultured into CM 
after 14 days and COL2 fibers were observed by immune gold staining between cells. In the 
Figure 3D and E were shown a spheroid cultured into CM plus 100 mg/ml of T3 after 14 days and 





Figure 2. Proteoglycan analyses from spheroid performed by mesenchymal stem cells (MSCs) of 
human umbilical cord stroma. (A) Representative images of tissue sections of spheroids performed 
by MSCs stained with Safranin O in chondrogenic medium (CM), CM plus 1,000 ng/ml of prolactin 
(CM + PRL), or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3). All images have the 
same magnification (bar = 2 mm). (B) Densitometry study of proteoglycan staining by Safranin O 
(Saf. O) from spheroids performed by MSCs cultured in chondrogenic medium (CM), CM plus 
1,000 ng/ml of prolactin (CM + PRL), or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine 
(CM + T3). (C) Real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) of 
ACAN gene in spheroids performed by MSCs cultured in chondrogenic medium (CM), CM plus 
1,000 ng/ml of prolactin (CM + PRL), or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine 





Figure 3. Chondrocyte-like cells study of spheroid performed by mesenchymal stem 
cell from human umbilical cord stroma. (A) Real time quantitative reverse transcriptase 
polymerase chain reaction (qRT-PCR) of the AP-2α, Ap-2ϵ, ITGa10, and COL2A1 
genes in spheroids performed by MSCs cultured in chondrogenic medium (CM) or CM 
plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3). Similar results were obtained 
from three independent experiments. *P < 0.05 versus CM by Mann–Whitney-U test. 
(B) Electron micrograph of a spheroid performed of MSCs from human umbilical cord 
human stroma after 2 days in chondrogenic medium (CM). Small bar represents 2.5 μm. 
(C) Electron micrograph of a spheroid performed of MSCs from human umbilical cord 
human stroma after 14 days in chondrogenic medium (CM). Small bar represents 
2.5 μm. (D) Electron micrograph of a spheroid performed of MSCs from human 
umbilical cord human stroma after 14 days in chondrogenic medium plus 100 ng/ml of 
3, 3′, 5-triiodo-L-thyronine (CM + T3). Small bar represents 2.5 μm. (E) Electron 
micrograph of a spheroid performed of MSCs from human umbilical cord human 
stroma after 14 days in chondrogenic medium plus 100 ng/ml of 3, 3′, 5-triiodo-L-
thyronine (CM + T3). Small bar represents 1 μm. 
 
  
The gene expression of SRC2 was demonstrated using qRT-PCR in MSCs before and after 
chondrogenic differentiation, so chondrocytes and cartilage from healthy human donors were used 
as a positive control (Fig. 4A). The chondrogenesis increase produced by T3 in our model of 
MSCs was inhibited when ML151, a specific inhibitor of SRC2, was added to the medium 1 h 
before T3 was added. Three dosages of ML151 (2.5, 10, and 20 μM) were assessed in CM alone 
(Fig. 4B). ML151 at 2.5 μM statistically significant reduced (P < 0.05) the gene expression ratio of 
COL2/COL1 in our model, compared to their expression in spheroids cultured with CM plus T3 
(Fig. 4C). Immunohistochemistry for COL2 and COL1 protein was also done and corroborated the 
results of the expression of their respective genes; all dosages of ML151 at 2.5 μM significantly 
reduced (P < 0.05) the ratio of staining of COL2/COL1 protein from that of spheroids cultured 




Figure 4. Role of SRC2, a steroid co-receptor of T3, on chondrogenesis of mesenchymal stem cells (MSCs) from human 
umbilical cord human stroma in spheroid cultures. (A) SRC2 gene expression by real time quantitative reverse transcriptase 
polymerase chain reaction (qRT-PCR) in human chondrocytes from healthy donors (CH), human cartilage from healthy 
donors (CART), human undifferentiated MSCs (UC MSCs 0D), and spheroids containing MSCs after 14 days in 
chondrogenic medium (CM) (UC MSCs14D). (B) Ratio COL2A1/COL1A1 gene expressions in spheroids containing MSCs 
cultured in chondrogenic medium (CM), CM plus 2.5 μM (INH2.5), 10 μM (INH 10), or 20 μM (INH 20) of the inhibitor of 
the T3 steroid co-receptor ML151 respectively by real time quantitative reverse transcriptase polymerase chain reaction 
(qRT-PCR). (C) Representative images of immunohistochemistry tissue sections with antibodies against human collagen 
type II (COL2) and collagen type I (COL1) protein in spheroids containing MSCs cultured in chondrogenic medium (CM), 
CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3), CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 
2.5 μM of ML151 (CM + T3 + INH 2.5). All images have the same magnification (bar = 200 μm). (D) Ratio of 
COL2/COL1 protein obtained from densitometry study from spheroids cultured in chondrogenic medium (CM), CM plus 
100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3), CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 2.5 μM of 
ML151 (CM + T3 + INH2.5). *P < 0.05 versus CM + T3 and #P < 0.05 versus CM by Mann–Whitney-U test. 
  
A study of hypertrophy in our model was made immunohistochemistry analysis to measure the 
staining of MMP-13, COLX, and ALP proteins (Fig. 5A and C) and the expression of their genes 
by qRT-PCR (Fig. 5B), including the study of expression of transcription factors Runx2 like a 
hypertrophy marker and Sox9 like a chondrogenic marker. Staining for MMP-13 was decreased 
significantly only when ML151 was added to the medium plus T3 (P < 0.05). Although, similar 
results were found in the qRT-PCR studies of the MMP-13 gene (Fig. 5B), the differences were 
not significant. COLX stain levels were significantly (P < 0.05) decreased in the spheroids cultured 
in CM when T3 was added to the medium from the levels in spheroids grown in CM. Compared to 
spheroids cultured in CM plus T3, the addition of ML151 significantly (P < 0.05) increased 
staining for COLX. Expression of Runx2 was increased when inhibitor ML151 was in the medium 
but was not statistically significant. However, the expression of Sox9 was statistically significant 
(P < 0.05) reduced when the inhibitor was in the medium (Fig. 5B). It is shown representative 
pictures with positive controls of all antibodies used in immunohistochemistry analysis and also 




Figure 5. 3, 3′, 5-triiodo-L-thyronine effects on hypertrophy in a chondrogenesis model using spheroid cultures of human 
umbilical cord mesenchymal stem cells (MSCs). (A) Densitometry study of human matrix metalloproteinase-13 (MMP-
13), collagen type 10 (COLX), and alkaline phosphatase (ALP) immunohistochemistry staining obtained from slices of 
spheroids containing MSCs cultured in chondrogenic medium (CM), CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine 
(T3), and CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 2.5 ng/ml of ML151 (Inh). (B) Representative images of 
tissue sections of spheroids containing MSCs immunostained with antibodies against MMP-13, COLX, and ALP cultured 
in chondrogenic medium (CM), CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3), or CM plus 100 ng/ml of 3, 
3′, 5-triiodo-L-thyronine plus 2.5 μM of ML151 (CM + T3 + Inh2.5). (C) MMP-13, COL10A1, and ALP gene expressions 
of spheroids containing MSCs cultured in chondrogenic medium (CM), plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (T3), 
and CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 2.5 ng/ml of ML151 (Inh) by real time quantitative reverse 
transcriptase polymerase chain reaction (qRT-PCR). *P < 0.05 versus CM; #P < 0.05 versus CM + T3 by Mann–Whitney-U 
test. 
  
Wnt EXPRESSION DURING CHONDROGENESIS 
The behavior of the Wnt family was studied by qRT-PCR and immunoblotting analysis in our 
chondrogenesis model. β-catenin, Frizzled, and GSK3-β gene expressions were increased when T3 
was present in the chondrogenic medium, all of them were statistically significant (P < 0.05). 
When ML151 was added to the medium, the β-catenin gene expression was statistically significant 
(P < 0.05) decreased versus its expression in CM plus T3 (Fig. 6A). Western blot analysis of the 
proteins revealed that β-catenin, Frizzled, and GSK-3B were statistically significant (P < 0.05) 
increased in CM plus T3 compared to CM alone; their levels decreased when ML151 at 2.5 μM 
was added to the CM plus T3 medium (Fig. 6B). 200 ng/ml of DKK-1 was added into CM 
resulting a reduction of B-catenin and Frizzled genes expressions and an increase GSK-3B gene 
expression respect their expression in CM alone, however, these genes inverted their expression 
when T3 was present in the medium, founding statistically significant (P < 0.05) increased the 
levels of B-catenin and Frizzled gene expressions and statistically significant (P < 0.05) decreased 
GSK-3gene expression (Fig. 6C) with respect their expression into CM plus DKK. These results 
were validated by Western blotting for B-catenin (Fig. 6D) and also the chondrogenic process was 
evaluated by immunohistochemistry of COL2 into spheroids formed during 14 days into CM when 
DKK-1 was added with or without T3. These results indicated that less COL2 was produced by 
spheroid cultured into CM plus DKK than COL2 was produced by spheroid cultured into CM plus 






Figure 6. Wnt pathway in a chondrogenesis model using spheroid cultures of human umbilical cord mesenchymal stem 
cells (MSCs). (A) Real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) of β-Catenin, 
Frizzled, and GSK-3β gene expressions in spheroids containing MSCs cultured in chondrogenic medium (CM), CM plus 
100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3) and CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 2.5 ng/ml 
of ML151 (CM + T3 + Inh). *P < 0.05 versus CM by Mann–Whitney-U test. (B) Detection of β-catenin, Frizzled and GSK-
3β proteins by Western blot in spheroids containing MSCs cultured in chondrogenic medium (CM), CM plus 100 ng/ml of 
3, 3′, 5-triiodo-L-thyronine (CM + T3), or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 2.5 ng/ml of ML151 
(CM + T3 + INH2.5). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or Tubulin were used as the control protein 
for western blots. (C) Real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) of β-Catenin, 
Frizzled, and GSK-3β gene expressions in spheroids containing MSCs cultured in chondrogenic medium plus 200 ng/ml of 
DKK-1(CM + DKK), chondrogenic medium plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 200 ng/ml of DKK-1 
(CM + T3 + DKK). *P < 0.05 versus CM + DKK by Mann–Whitney-U test. (D) Representative images of 
immunohistochemistry tissue sections with antibody against human collagen type II (COL2) in spheroids containing MSCs 
cultured in chondrogenic medium (CM), or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3) or CM plus 
200 ng/ml of DKK (CM + DKK) or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 200 ng/ml of DKK 
(CM + T3 + DKK). All images have the same magnification (bar = 2 mm). (E) Representative images of 
immunohistochemistry tissue sections with antibody against human collagen type 2 (COL2) in spheroids containing MSCs 
cultured in chondrogenic medium (CM), or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3) or CM plus 
200 ng/ml of DKK (CM + DKK) or CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine plus 200 ng/ml of DKK 
(CM + T3 + DKK). All images have the same magnification (bar = 2 mm). F) Real time quantitative reverse transcriptase 
polymerase chain reaction (qRT-PCR) of COL2A1 gene expression in spheroids containing MSCs cultured in chondrogenic 
medium (CM), CM plus 100 ng/ml of 3, 3′, 5-triiodo-L-thyronine (CM + T3), CM plus 200 ng/ml of DKK (CM + DKK), 




Chondrocyte proliferation and differentiation are regulated by various endocrine, paracrine, 
and autocrine agents, including growth, thyroid and sex hormones, beta-catenin, bone 
morphogenetic proteins, insulin-like growth factor, iodothyronine deiodinase, leptin, nitric oxide, 
transforming growth factor-β, and vitamin D metabolites [Burdan et al., 2009]. Our group directed 
the differentiation of MSCs from human different tissues like synovial membrane toward 
chondrocyte-like cells testing different mediums and standard micromass conditions, that is, as 
pellets [Arufe et al., 2009, 2010], it was demonstrated that spheroid culture of MSC is a valuable 
method to direct differentiation towards chondrocyte-like cells, however, an optimum amount of 
aggrecan, the most important proteoglycan in the extracellular matrix of the joint cartilage, was not 
consistently achieved [Arufe et al., 2011a]. Characterization of MSCs from umbilical cord source 
by flow cytometry showed in the Figure 1A confirm previous results already published [Arufe et 
al., 2011b; De la Fuente et al., 2012; Kawata et al., 2012], indicating that our MSCs from human 
umbilical cord stroma present MSCs markers. Different dosages of T3 and PRL were added to 
chondrogenic medium to test their effect on chondrogenesis founding PRL had no effect on the 
chondrogenic process that could be found by qRT-PCR or immunohischemistry analyses. These 
results were in concordance with results published by Seriwatanachai et al. [2012] who provided 
evidence that the PRL increased endochondral bone growth and bone elongation, presumably by 
accelerating apoptosis of hypertrophic chondrocytes in the growth plate and/or subsequent 
chondrogenic matrix mineralization but not related with chondrogenesis onset. After performing 
dose-response experiments, qRT-PCR and immunohistochemistry results indicated that T3 at 
100 ng/ml after 14 days in CM culture produced a significant increase in the expression of COL2 
(Fig. 1B) and ACAN genes and Safranin O staining over that found with chondrogenic medium 
alone (Fig. 2A–C). Boeloni et al. [2009] published dose-dependent results of T3 effect on the 
osteogenic differentiation using rat bone marrow mesenchymal stem cells and they regarded the 
conclusion that 1 pM T3 dose resulted in greater collagen synthesis and alkaline phosphatase 
activity than greater dose like our work where 100 ng/ml of T3 is a bigger dose than 1 pM but it 
keep being a physiological dose. We decided focusing all the experiments only at 14 days of 
differentiation like several recent published papers in the field [Perry et al., 2006; Weimer et al., 
2007; Hardy et al., 2008]. The quality of our chondrogenic model was evaluated by RT-PCR 
checking genes related to chondrogenesis like AP2α, ITGa10, COL2, and AP2ϵ [Camper et al., 
2001; Freyria et al., 2009; Ronzière et al., 2010]. AP-2ϵ is involved in the regulation of ITGa10 
transcription in chondrocytes [Wenke et al., 2006] and it is considered a hyperthrophic marker 
Niebler and Bosserhoff [2013] showed that AP-2ϵ was increased during late chondrocyte 
differentiation, especially in hypertrophic chondrocytes. However, AP-2α is expressed in the 
growth plate and in articular cartilage and has been described as a negative regulator of 
chondrocyte differentiation [Huang et al., 2004], maintaining cells in an early differentiate 
phenotype. We observed in our chondrogenic model that both factors are increased with T3 
treatment but the AP-2α increase is the biggest and this result might explain the chondrogenic 
action of T3 in our model as well as the statistically significant increase of COL2 and this fact 
might also explain we do not find hypertrophy in our model (Fig. 3A). The electronic microscopy 
analysis of our spheroids corroborated the increase of COL2 fibres in the gaps between cells (Fig. 
3B–D). 
 
We used ML151 to block SRC2 after confirming that SRC2 was present in our cells (Fig. 4A). 
Although, there were differences in the expression level of the SRC2 gene between the MSCs 
treated with different concentrations of inhibitor in the CM without T3 to eliminate possible 
interaction of this inhibitor on chondrogenesis by itself (Fig. 4B). The inhibitor probe molecule, 
ML151 (CID 5184800), blocked the TRβ-SRC2 interaction. Mechanistic studies revealed that 
ML151 is a covalent inhibitor and binds irreversibly to Cys298 within the AF-2 cleft of TRβ. This 
series will be useful for in vitro mechanistic studies of TR-SRC2 interactions, as well as other 
nuclear hormone receptor-co activator interactions [Johnson et al., 2011]. Our results indicated 
that 2.5 μM of ML151 is enough to nullify the chondrogenesis increase achieved with T3, causing 
a significant decrease of COL2 and ACAN gene expressions, compared to their levels in CM plus 
T3 (Fig. 4C–E). 
 
Results of a previous study published by Mueller and Tuan [2008] supported the roles of T3 
and TGF-β in cartilage maturation; TGF-β stimulated proliferation and suppressed hypertrophy, 
although T3 stimulated hypertrophy and apoptosis. On the opposite way, in our model the role of 
T3 seems to promote chondrogenesis with no hypertrophy, T3 treatment did not increase, even 
reduce MMP13, COLX, and ALP signal by immunohistochemistry analysis in spheroid after 14 
days (Fig. 5A and B) as expected as referred by studies published by Mueller and Tuan [2008] and 
Liu et al. [2012]. Our results might be explained because of few days in culture and the source 
from our MSCs was different from used for those authors and the most important was that the T3 
dose used in this work was physiological and very low in front of dose used for those authors. 
 
It is possible that combination of TGF-β withdrawal, a reduction in the level of 
dexamethasone, and the addition of T3 was essential for hypertrophy induction in the Muelleŕs 
work. Also Runx2 gene expression was evaluated by RT-PCR to check hypertrophy or increase of 
osteogenesis at genetic level as made Liu et al. [2012] in their paper and it was not hypertrophy 
increased in our work when T3 was added to CM (Fig. 5C). Jiang et al. [2008] used T3 to 
stimulate articular chondrocyte hypertrophy and mineralization in primary chondrocyte monolayer 
cultures over a long time period. However, the results obtained in our study indicate that T3, 
together with TGF-β3, increased ACAN expression in the extracellular matrix from chondrocyte-
like cells engineered from MSCs of human umbilical cord stroma in our chondrogenesis model as 
early as 14 days (Fig. 2). This does not contradict the possibility that hypertrophy may appear in 
our model over a longer time; this point was not addressed in this study at this time. 
 
Wnt signalling pathways are the two most important signalling pathways that play key roles in 
embryonic development and in the biology of MSCs, including cell proliferation, differentiation, 
and epithelial-mesenchymal interaction [Sarkar et al., 2010; Centola et al., 2013; Baghaban 
Eslaminejad and Fallah, 2014]. Wnt signalling pathway represents two major channels of 
communication used by animal cells to control their identity and behavior during development. 
Hayward and Kalmar Arias [2008] reviewed the evidence for the relationship between Wnt 
signalling, which act as components of an integrated device that, rather than defining the fate of a 
cell, determines the probability that a cell would adopt that fate. Our results indicated that the 
presence of T3 in the chondrogenic medium increased gene expression and protein levels of β-
catenin and Frizzled, as well as GSK-3β (Fig. 6A and B). These results agree with those published 
by Wang et al. [2007], who suggested that this accumulation of proteins could be resulted from a 
decrease in their degradation. Day et al. [2005] demonstrated that β-catenin was essential in 
determining whether mesenchymal progenitor cells would become osteoblasts or chondrocytes 
regardless of regional locations or ossification mechanisms. Similarly, our results seem to indicate 
that an increase of chondrogenesis produced by adding T3 in the chondrogenic medium would be 
mediated by β-catenin because of it was increased in the cells treated with T3 (Fig. 6A and B) as 
well as increased the COL2A1 expression and COL2 in those cells (Fig. 1B and C). On the 
opposite way the decrease of β-catenin produced by ML151, which blocks SRC2 precluding the 
T3 actuation, also decreased the chodrogenesis process, as indicated by the decrease of COL2 
production (Fig. 4C and D). However ML151 looks like be affecting expression of β-catenin 
independently of Frizzled and GSK-3B expression how demonstrate the results found by RT-PCR 
and Western blotting analysis (Fig. 6C and D). Dickkopf-related protein 1 (DKK-1) is a member 
of the Dkk protein family and an antagonist for Wnt signalling [Guerrero et al., 2014; Liu et al., 
2014], which inhibits the translocation of β-catenin into the nucleus and its link on LRP5/6 
component. Supplementation of Dkk-1 into CM plus T3 did not diminished levels of β-catenin in 
spheroid after 14 days because the expression of β-catenin increased comparing with CM alone 
plus Dkk-1 and this increasing was statistically significant (P < 0.05) by western blot analysis (Fig. 
6E), these results were corroborated by qRT-PCR and immunohistochemistry analysis (Fig. 
6C,D,F). Leijten et al. [2012] using human cartilage found similarly than we found into our in 
vitro analysis, where it looks like indicate that T3 is acting through SRC2 directly on β-catenin 
preventing the union of DKK-1 on LRP5/6 component. 
CONCLUSION 
T3, in a physiological amount, stimulates the chondrogenesis process without stimulating 
hypertrophy in an in vitro model using human MSCs; this effect is mediated through SRC2. T3 
chondrogenic effect is modulated by Wnt pathway independently of LRP5/6 component. Overall 
our results present new possibilities for cellular plus hormonal treatments as therapeutic strategies 
for regeneration of tissues, including cartilage. 
ACKNOWLEDGMENTS 
The authors wish to thank Mrs. Purificación Filgueira Fernández and Mrs. Noa Goyanes and 
Mrs. María José Sánchez Dopico for technical support. This study was supported by a grant from 
Instituto de Salud Carlos III—Ministerio Economía y Competitividad N° Expediente PI11/02799 
Unión Europea—Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer 
Europa.” 
REFERENCES 
Arufe MC, De la Fuente A, Fuentes-Boquete I, De Toro FJ, Blanco FJ. 2009. Differentiation of synovial CD-
105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J Cell 
Biochem 108(1):145–155.  
Arufe MC, De la Fuente A, Diaz S, Fuentes I, De Toro FJ, Blanco FJ. 2010. Chondrogenic potential of 
subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial 
membranes. Osteoarthritis Cartilage 18:S80–S81.  
Arufe MC, De la Fuente A, Fuentes I, Toro FJ, Blanco FJ. 2011a. Umbilical cord as a mesenchymal stem cell 
source for treating joint pathologies. World J Orthop 2(6):43–50.  
Arufe MC, De la Fuente A, Mateos J, Fuentes I, De Toro FJ, Blanco FJ. 2011b. Analysis of the chondrogenic 
potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem 
Cells Dev 20(7):1199–1212.  
Baghaban Eslaminejad M, Fallah N. 2014. Small molecule-BIO accelerates and enhances marrow-derived 
mesenchymal stem cell in vitro chondrogenesis. Iran J Med Sci 39(2):107–116.  
Boeloni JN, Ocarino NM, Melo AB, Silva JF, Castanheira P, Goes AM, Serakides R. 2009. Dose-dependent 
effects of triiodothyronine on the osteogenic differentiation of rat bone marrow mesenchymal stem cells. 
Horm Res 72(2):88–97.  
Burdan F, Szumiło J, Korobowicz A, Farooquee R, Patel S, Patel A, Dave A, Szumiło M, Solecki M, Klepacz 
R, Dudka J. 2009. Morphology and physiology of the epiphyseal growth plate. Folia Histochem Cytobiol 
47(1):5–16.  
Camper L, Holmvall K, Wängnerud C, Aszódi A, Lundgren-Akerlund E. 2001. Distribution of the collagen-
binding integrin alpha10beta1 during mouse development. Cell Tissue Res 306(1):107–116.  
Centola M, Tonnarelli B, Schären S, Glaser N, Barbero A, Martin I. 2013. Priming 3D cultures of human 
mesenchymal stromal cells toward cartilage formation via developmental pathways. Stem Cells Dev 
22(21):2849–2858.  
Clément-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, 
Gaillard-Kelly M, Binart N, Baron R, Kelly PA. 1999. Osteoblasts are a new target for prolactin: 
Analysis of bone formation in prolactin receptor knockout mice. Endocrinology 140(1):96–105.  
Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR. 
1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12(21):3343–
3356.  
Day TF, Guo X, Garrett-Beal L, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors 
controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8(5):739–
750.  
De la Fuente A, Mateos J, Lesende-Rodríguez I, Calamia V, Fuentes-Boquete I, de Toro FJ, Arufe MC, 
Blanco FJ. 2012. Proteome analysis during chondrocyte differentiation in a new chondrogenesis model 
using human umbilical cord stroma mesenchymal stem cells. Mol Cell Proteomics 11(2):M111.010496.  
Freyria AM, Ronzière MC, Cortial D, Galois L, Hartmann D, Herbage D, Mallein-Gerin F. 2009. 
Comparative phenotypic analysis of articular chondrocytes cultured within type I or type II collagen 
scaffolds. Tissue Eng Part A 15(6):1233–1245.  
Guerrero F, Herencia C, Almadén Y, Martínez-Moreno JM, Montes de Oca A, Rodriguez-Ortiz ME, Diaz-
Tocados JM, Canalejo A, Florio M, López I, Richards WG, Rodriguez M, Aguilera-Tejero E, Muñoz-
Castañeda JR. 2014. TGF-é prevents phosphate-induced osteogenesis through inhibition of BMP and 
Wnt/é-catenin pathways. PLoS ONE 9(2):e89179.  
Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM, Gittoes NJ, Buckley CD, Raza K, Cooper 
MS. 2008. Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis 
67:1204–1210.  
Hayward P, Kalmar Arias TAM. 2008. Wnt/Notch signalling and information processing during 
development. Development 135(3):411–424.  
Huang Z, Xu H, Sandell L. 2004. Negative regulation of chondrocyte differentiation by transcription factor 
AP-2alpha. J Bone Miner Res 19(2):245–255.  
Jiang J, Leong NL, Mung JC, Hidaka C, Lu HH. 2008. Interaction between zonal populations of articular 
chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP. 
Osteoarthritis Cartilage 16(1):70–82.  
Johnson RL, Hwang JY, Arnold LA, Huang R, Wichterman J, Augustinaite I, Austin CP, Inglese J, Guy RK, 
Huang W. 2011. A quantitative high-throughput screen identifies novel inhibitors of the interaction of 
thyroid receptor beta with a peptide of steroid receptor coactivator 2. J Biomol Screen 16(6):618–627.  
Kawata K, Kubota S, Eguchi T, Aoyama E, Moritani NH, Kondo S, Nishida T, Takigawa M. 2012. Role of 
LRP1 in transport of CCN2 protein in chondrocytes. J Cell Sci 125(Pt 12):2965–2972.  
Leijten JC, Emons J, Sticht C, van Gool S, Decker E, Uitterlinden A, Rappold G, Hofman A, Rivadeneira F, 
Scherjon S, Wit JM, van Meurs J, van Blitterswijk CA, Karperien M. 2012. Gremlin 1, frizzled-related 
protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum 
64(10):3302–3312.  
Liu Y, Zhou J, Zhao W, Li X, Jiang R, Liu C, Guo FJ. 2012. XBP1S associates with RUNX2 and regulates 
chondrocyte hypertrophy. J Biol Chem 287(41):34500–34513.  
Liu W, Konermann A, Guo T, Jäger A, Zhang L, Jin Y. 2014. Canonical Wnt signaling differently modulates 
osteogenic differentiation of mesenchymal stem cells derived from bone marrow and from periodontal 
ligament under inflammatory conditions. Biochim Biophys Acta 1840(3):1125–1134.  
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR 
and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408.  
Lunstrum GP, Keene DR, Weksler NB, Cho YJ, Cornwall M, Horton WA. 1999. Chondrocyte differentiation 
in a rat mesenchymal cell line. J Histochem Cytochem 47(1):1–6.  
Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. 1994. D-type cyclin-dependent 
kinase activity in mammalian cells. Mol Cell Biol 14(3):2066–2076.  
Moore JM, Galicia SJ, McReynolds AC, Nguyen NH, Scanlan TS, Guy RK. 2004. Quantitative proteomics of 
the thyroid hormone receptor-coregulator interactions. J Biol Chem 279(26):27584–27590.  
Mueller MB, Tuan RS. 2008. Functional characterization of hypertrophy in chondrogenesis of human 
mesenchymal stem cells. Arthritis Rheum 58(5):1377–1388.  
Niebler S, Bosserhoff AK. 2013. The transcription factor activating enhancer-binding protein epsilon (AP-2ϵ) 
regulates the core promoter of type II collagen (COL2A1). FEBS J 280(6):1397–1408.  
Ogueta S, Muñoz J, Obregon E, Delgado-Baeza E, García-Ruiz JP. 2002. Prolactin is a component of the 
human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-
derived mesenchymal stem cells. Mol Cell Endocrinol 190(1–2):51–63.  
Park S, Kim E, Koh SE, Maeng S, Lee WD, Lim J, Shim I, Lee YJ. 2012. Dopaminergic differentiation of 
neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease 
model rats and alleviation of asymmetric rotational behavior. Brain Res 1466:158–166.  
Perry JJ, Yannone SM, Holden LG, Hitomi C, Asaithamby A, Han S, Cooper PK, Chen DJ, Tainer JA. 2006. 
WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing. Nat 
Struct Mol Biol 13:414–422.  
Ronzière M, Perrier E, Mallein-Gerin F, Freyria A. 2010. Chondrogenic potential of bone marrow- and 
adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng 20(3):145–158.  
Sarkar FH, Li Y, Wang Z, Kong D. 2010. The role of nutraceuticals in the regulation of Wnt and Hedgehog 
signaling in cancer. Cancer Metastasis Rev 29(3):383–394.  
Seriwatanachai D, Krishnamra N, Charoenphandhu N. 2012. Chondroregulatory action of prolactin on 
proliferation and differentiation of mouse chondrogenic ATDC5 cells in 3-dimensional micromass 
cultures. Biochem Biophys Res Commun 420(1):108–113.  
Subramanian A, Fong CY, Biswas A, Bongso A. 2015. Comparative characterization of cells from the 
various compartments of the human umbilical cord shows that the Wharton's jelly compartment provides 
the best source of clinically utilizable mesenchymal stem cells. PLoS ONE 10(6):e0127992.  
Suntornsaratoon P, Wongdee K, Goswami S, Krishnamra N, Charoenphandhu N. 2010a. Bone modeling in 
bromocriptine-treated pregnant and lactating rats: Possible osteoregulatory role of prolactin in lactation. 
Am J Physiol Endocrinol Metab 299(3):E426–E436.  
Suntornsaratoon P, Wongdee K, Krishnamra N, Charoenphandhu N. 2010b. Femoral bone mineral density 
and bone mineral content in bromocriptine-treated pregnant and lactating rats. J Physiol Sci 60(1):1–8.  
Suntornsaratoon P, Wongdee K, Krishnamra N, Charoenphandhu N. 2010c. Possible chondroregulatory role 
of prolactin on the tibial growth plate of lactating rats. Histochem Cell Biol 134(5):483–491.  
Wang L, Shao YY, Ballock RT. 2007. Thyroid hormone interacts with the Wnt/beta-catenin signaling 
pathway in the terminal differentiation of growth plate chondrocytes. J Bone Miner Res 22(12):1988–
1995.  
Weimer JM, Benedict JW, Elshatory YM, Short DW, Ramirez-Montealegre D, Ryan DA, Alexander NA, 
Federoff HJ, Cooper JD, Pearce DA. 2007. Alterations in striatal dopamine catabolism precede loss of 
substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Res 1162:98–
112.  
Wenke AK, Rothhammer T, Moser M, Bosserhoff AK. 2006. Regulation of integrin alpha10 expression in 
chondrocytes by the transcription factors AP-2epsilon and Ets-1. Biochem Biophys Res Commun 
345(1):495–501. 
 
